Details
Stereochemistry | RACEMIC |
Molecular Formula | C12H16O4 |
Molecular Weight | 224.253 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 2 / 2 |
E/Z Centers | 1 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CCC\C=C1/OC(=O)C2=C1CC[C@H](O)[C@H]2O
InChI
InChIKey=DQNGMIQSXNGHOA-JXQVETIVSA-N
InChI=1S/C12H16O4/c1-2-3-4-9-7-5-6-8(13)11(14)10(7)12(15)16-9/h4,8,11,13-14H,2-3,5-6H2,1H3/b9-4-/t8-,11+/m0/s1
Molecular Formula | C12H16O4 |
Molecular Weight | 224.253 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 2 / 2 |
E/Z Centers | 1 |
Optical Activity | UNSPECIFIED |
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/27919258Curator's Comment: description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/21235591
Sources: https://www.ncbi.nlm.nih.gov/pubmed/27919258
Curator's Comment: description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/21235591
Senkyunolide I is an active ingredient of Rhizoma Chuanxiong, a Chinese medicinal herb commonly used for the treatment of cardiovascular ailments. Senkyunolide I is presentative metabolite of ligustilide in vivo and in vitro, is one of the most important bioactive constituents of chuanxiong. It was fount, that it could treat migraines, although the mechanism is unclear.
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/27919258
in rats: oral administration at a dose of 100 mg*kg−1/body weight
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/27524398
Curator's Comment: It was found, that senkyunolide I (SEI) suppressed the activation of NF-κB pathway induced by oxygen-glucose deprivation/reoxygenation (OGD/R) and the MAPK pathway was shown not to be involved. Furthermore, SEI significantly down-regulated TLR4/MyD88 pathway with specifically improving inducible Hsp70 level through increasing HSF-1/DNA binding activity. SEI exerted similar influence on Hsp70/TLR4/NF-κB pathway in rat primary microglial cells. The results suggested that SEI had a potent effect against stroke-induced neuroinflammation through suppressing the TLR4/NF-κB pathway by up-regulating Hsp70 dependent on HSF-1.
Unknown
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 08:29:19 GMT 2023
by
admin
on
Sat Dec 16 08:29:19 GMT 2023
|
Record UNII |
12PJ07292V
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
DTXSID001317406
Created by
admin on Sat Dec 16 08:29:19 GMT 2023 , Edited by admin on Sat Dec 16 08:29:19 GMT 2023
|
PRIMARY | |||
|
12PJ07292V
Created by
admin on Sat Dec 16 08:29:19 GMT 2023 , Edited by admin on Sat Dec 16 08:29:19 GMT 2023
|
PRIMARY | |||
|
88551-87-5
Created by
admin on Sat Dec 16 08:29:19 GMT 2023 , Edited by admin on Sat Dec 16 08:29:19 GMT 2023
|
ALTERNATIVE | |||
|
11521428
Created by
admin on Sat Dec 16 08:29:19 GMT 2023 , Edited by admin on Sat Dec 16 08:29:19 GMT 2023
|
PRIMARY | |||
|
94596-28-8
Created by
admin on Sat Dec 16 08:29:19 GMT 2023 , Edited by admin on Sat Dec 16 08:29:19 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> CONSTITUENT ALWAYS PRESENT |
Senkyunolide I, coniferyl ferulate, senkyunolide A, 3-butylphthalide, Z-butylidenephthalide and levistolide A were isolated from essential oil of Angelica sinensis.
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> METABOLITE ACTIVE |
MAJOR
|